» TAT 2010 meeting, March 4-6, with NCI and ESMO

home / conferences / TAT 2010
 
 
Symposium
   
 


8th INTERNATIONAL SYMPOSIUM ON TARGETED ANTICANCER THERAPIES

Bethesda, MD, USA, March 4-6, 2010

 
     
 

Sponsors & exhibitors

TAT 2010 is supported by educational grants provided by:


Amgen
ArQule
Bristol-Myers Squibb
Celgene
ImClone Systems *
Lilly USA, LLC **
OSI Oncology

* a wholly-owned subsidiary of Eli Lilly and Company; for further information concerning ImClone Systems grant funding visit www.imclonegrantoffice.com.
** for further information concerning Lilly grant funding visit www.lillygrantoffice.com.


Corporate sponsorship:


Scholarship grants:

NCI Center for Cancer Research
Pfizer Oncology


TAT 2010 homepage

Organization & partners

Committees

Program

CME

Presentations online (n.a.)
MDICT Task Force
Next meeting (n.a.)
Contact